Contineum Therapeutics (CTNM) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist

14.960
-0.350-2.29%

Close May 16 16:00 ET

384.82MMarket Cap-115968P/E (TTM)

Pre-Market

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Contineum Therapeutics, Inc. Class A (CTNM) Gets a Buy From RBC Capital
TipRanks06:27 ET
Contineum Therapeutics | 10-Q: Quarterly report
SEC announcement17:04 ET · Announcements
Express News | Contineum Therapeutics Q3 EPS $(3.55), Cash Position $117.9M
Benzinga16:26 ET
Express News | Contineum Therapeutics Inc - Qtrly Shr Loss $3.55
Reuters16:10 ET
Contineum Therapeutics 1Q Loss/Shr $3.55 >CTNM
Contineum Therapeutics 1Q Loss/Shr $3.55 >CTNM
Dow Jones16:06 ET
Express News | Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Reuters16:05 ET

Comments

Pinchie McPincher

Apr 19 03:23

$Contineum Therapeutics(CTNM.US)$what am i missing?

Jaguar8

Apr 4 22:56

$Contineum Therapeutics(CTNM.US)$
NEWS
Contineum Therapeutics, Inc. announces pricing of IPO, offering 6,875,000 shares of Class A common stock at $16.00 per share, expecting gross proceeds of $110.0 million. Shares to trade on Nasdaq under symbol 'CTNM'.